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Insights into the Relationship between
Nucleolar Stress and the NF-κB PathwayJingyu Chen1 and Lesley A. Stark 1,2,*,@Highlights
Nucleoli play a critical role in maintaining
cellular homeostasis in health, ageing,
and disease, as does the NF-κB tran-
scription factor pathway. Emerging data
suggest that interplay between these
two cellular factors regulates cell growth
and death.
An atypical nucleolar stress response
pathway, characterized by degradation
of the PolI complex component, TIF-IA,
and nucleolar enlargement, lies up-The nuclear organelle the nucleolus and the transcription factor nuclear factor of
κ-light-chain-enhancer of activated B cells (NF-κB) are both central to the control
of cellular homeostasis, dysregulated in common diseases and implicated in the
ageing process. Until recently, it was believed that they acted independently to
regulate homeostasis in health and disease. However, there is an emerging body
of evidence suggesting that nucleoli and NF-κB signalling converge at multiple
levels. Here we will review current understanding of this crosstalk. We will discuss
activation of the NF-κB pathway by nucleolar stress and induction of apoptosis by
nucleolar sequestration of NF-κB/RelA. We will also discuss the role of TIF-IA,
COMMD1, and nucleophosmin, which are key players in this crosstalk, and the
therapeutic relevance, particularly with respect to the antitumour effects of aspirin.stream of NF-κB pathway activation.
Components of the NF-κB complex ac-
cumulate in nucleoli in response to
stress. The presence of RelA in nucleoli
triggers cytoplasmic relocation of
nucleophosmin which mediates apopto-
sis by transporting BAX to mitochondria.
The chemopreventive agent aspirin trig-
gers TIF-IA–NF-κB signalling in human
colorectal tumours, which is important
for its antitumour activity.
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There are many parallels between nucleoli and the nuclear factor of κ-light-chain-enhancer of ac-
tivated B cells (NF-κB) transcription factor. For example, both are stimulated by the same plethora
of stresses (Table 1), both regulate the same downstream physiological processes, both are dys-
regulated in a variety of common diseases which contributes to disease aetiology, and both are
implicated in senescence and ageing [1–6]. Until recently, it was believed that these factors act
independently to regulate cellular homeostasis in health, ageing, and disease. However, there
is a growing body of evidence to suggest that nucleolar stress activates the NF-κB pathway,
and that nucleolar sequestration of NF-κB components is a critical apoptotic regulator. Here
we will review the various levels of convergence between NF-κB and the nucleolus. We will also
discuss the relevance of nucleoli–NF-κB crosstalk to the antitumour mechanisms of aspirin and
the potential relevance to senescence and ageing.
The Multifunctional Nucleolus
The nucleolus is a highly dynamic, multifunctional, subnuclear organelle [3,4,7]. Its most
established role is as the hub of ribosome biogenesis, the process by which rRNA is transcribed,
cleaved, and assembled into ribosomes (Figure 1). This process is the most energy consuming in
the cell and as such, is tightly linked to metabolic and proliferative activity. The starting point, and
arguably the rate-limiting step, is transcription of ribosomal DNA (rDNA) by the RNA polymerase I
(PolI) preinitiation complex (PIC). This complex includes upstream binding factor (UBF), which
acts as derepressor and coactivator; SL1 proteins, which confer promotor specificity; and TIF-
IA (gene name RRN3), which is essential as it tethers PolI to the rDNA promoter [8]. The output
of rDNA transcription is the 47S preribosomal RNA transcript, which is cotranscriptionally ma-
tured through nucleolytic processing and assembly with ribosomal proteins and cofactors, to
eventually generate the 40S and 60S ribosomal subunits [9].
In addition to its traditional role in ribosome biogenesis, the nucleolus plays a critical role in pro-
cesses such as signal recognition particle assembly [10], pre-tRNAmaturation [11], telomerase
assembly [12], ribonucleoprotein biogenesis [13], and even organization of the epigenomeTrends in Genetics, Month 2019, Vol. xx, No. xx https://doi.org/10.1016/j.tig.2019.07.009 1
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Table 1. Stress Stimuli Disrupt Nucleoli and Activate NF-κBa
Stress type Stimulus Activation of
NF-κB
Refs Nucleolar
disruption
Refs
DNA damage/genotoxic stress UV-C Yes [109,110] Yes [63,111–113]
Gamma irradiation Yes Yes
Camptothecin Yes [109,114] Yes
Bleomycin Yes Yes
Oxidative stress Reactive oxygen intermediate Yes [115] Yes [116,117]
Hypoxia Yes [118] Yes
Chemotherapeutic/chemopreventive
agents
Doxorubicin Yes [119] Yes [120]
Etoposide Yes [114] [112]
Aspirin/nonsteroidal anti-inflammatory
drugs
Yes [81,82] Yes [1]
Nutrient stress Serum starvation Yes [81] Yes [54]
Oncogenic stress Ras/BCR-ABL Yes [2] Yes [121]
aAdapted from [1].
Trends in Genetics[14,15]. Another key role for nucleoli is in the coordination of the cellular stress response
(Figure 1) [3,16]. If cellular homeostasis is disrupted, for example, by nutrient deprivation,
exposure to cytotoxic agents, viral infection, or oncogene inactivation, PolI-driven transcription is
rapidly downregulated and a cascade of signalling events is triggered that influences cell physiol-
ogy. This process is broadly termed nucleolar stress and can take many forms, dependent on
cell context and the nature of the insult [14,17]. Outcomes associated with nucleolar stress include
differentiation, cell cycle arrest, autophagy, DNA repair, senescence, and apoptosis [4,16,18,19].
The paradigm of nucleolar stress response is inhibition of rDNA transcription leading to stabiliza-
tion of p53 [20,21]. While this is undoubtedly an important mechanism by which the organelle reg-
ulates cellular homeostasis, there are multiple lines of evidence indicating nucleoli can control
apoptosis, senescence, and autophagy in a p53-independent manner [19,22–24]. New research
has revealed activation of the NF-κB pathway as an alternative keymechanism by which nucleolar
stress regulates cell growth and death.
Nucleolar Stress and Activation of the NF-κB Pathway
NF-κB is a family of highly conserved, inducible transcription factors that play a critical role not
only in innate and adaptive immunity, but also in stress response and the maintenance of cellular
homeostasis [2,25]. The family comprise five members, namely, RelA (p65), RelB, c-Rel, p105/
p50 (NF-κB1), and p100/p52 (NF-κB2). All members have a Rel homology domain which allows
dimerization, translocation to the nucleus, and DNA binding, while only RelA, RelB, and C-Rel
have the ability to drive transcription. The most abundant form of NF-κB, and the primary
mediator of NF-κB-dependent stress response, is the RelA:P50 heterodimer. In resting cells,
this complex is held in the cytoplasm by the inhibitor of NF-κB (IκB) protein, IκBα [26,27]. When
the cell is exposed to a wide array of stimuli, for example, inflammatory cytokines, bacterial
pathogens, cytotoxic agents, DNA damaging agents, nutrient deprivation, hypoxia, and physical
insult, IκBα is phosphorylated and targeted for degradation by the 26S proteasome. This
unmasks the nuclear localization signal on RelA, allowing NF-κB dimers to translocate to the
nucleus and influence expression of over 150 target genes [28]. These genes control a broad
range of physiological processes including proliferation, differentiation, senescence, cell cycle
progression, and apoptosis.2 Trends in Genetics, Month 2019, Vol. xx, No. xx
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Figure 1. The Multifunctional Nucleolus. (A) Schematic demonstrating the nucleolus as the hub of ribosome biogenesis and as a critical regulator of cellular
homeostasis. Ribosome biogenesis starts with transcription of the 47S pre-rRNA transcript by the PolI preinitiation complex (inset). The 47S transcript is cleaved and
packaged to eventually generate the 40S and 60S ribosomal subunits. The function of the nucleolus is altered by a plethora of environmental and oncogenic stresses.
This change in nucleolar function alters numerous cellular processes so that the cell can recover, or if the damage is too great, undergo cell death. There are thousands
of regulatory proteins within nucleoli that have roles beyond ribosome biogenesis. It is believed to be the dynamic flux of these proteins to the nucleoplasm/cytoplasm
following nucleolar stress that stimulates downstream signalling networks. (B) TIF-IA is targeted by multiple kinases and phosphatases dependent on environmental
conditions, which controls the transcriptional output of the preinitiation complex and nucleolar function. Abbreviations: AMPK, AMP-activated protein kinase; CDK,
cyclin-dependent kinase; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; mTOR, mammalian target of rapamycin; NES, nuclear export signal.
NLS, nuclear localization signal; PolI, RNA polymerase I; RSK, ribosomal s6 kinase; UBF, upstream binding factor.
Trends in GeneticsA number of upstream pathways have been described that lead to degradation of IκB. The most
established of these is the canonical pathway. This is induced by classic NF-κB stimuli [such as
tumour necrosis factor alpha (TNFα)] and is characterized by rapid phosphorylation of IκBα by
the inhibitor of κB kinase (IKK) complex [27]. By contrast, stress stimuli generally induce IκB phos-
phorylation/degradation with a delayed and slow kinetic. Specific mechanisms have been pro-
posed for this delayed response [29–33]. However, how multiple heterogeneous stresses
converge on the NF-κB pathway has been far from clear. Intuitively, given the parallels betweenTrends in Genetics, Month 2019, Vol. xx, No. xx 3
Trends in Geneticsstresses that disrupt ribosome biogenesis and those that activate NF-κB (Table 1), nucleolar dis-
ruption could provide a unifying mechanism. Indeed, a number of nucleolar proteins are known to
regulate NF-κB signalling. Furthermore, an atypical form of nucleolar stress has recently been
shown to lie upstream of NF-κB pathway activation.
Nucleolar Proteins Regulate NF-κB Signalling
The nucleolar proteome contains over 4500 proteins that shuttle dynamically between this and
other cellular compartments, depending on cell context [34]. Several studies have shown the im-
portance of such nucleolar proteins in the regulation of NF-κB signalling, especially in response to
stress. For example, casein kinase type 2 (CK2), which is bound to TIF-IA in the PolI complex [35],
has previously been shown to phosphorylate IκBα in response to UV-C, potentiating NF-κB path-
way activation [30,36]. Similarly, phosphorylation of eIF2α in response to endoplasmic reticulum
stress can both inhibit PolI activity [37] and activate NF-κB [31,32]. The nucleolar protein p14ARF,
which sequesters MDM2 in the nucleolus to regulate p53 stability [38], interacts with RelA and in-
hibits NF-κB-driven transcription [39]. NIK (NF-κB-inducing kinase), which acts upstream of the
IKK complex to stimulate NF-κB signalling [40], is a nucleolar shuttling protein [41], as is NF-κB
repressing factor (NKRF), which modulates rRNA processing in response to heat stress and re-
presses NF-κB-driven transcription [42,43]. Finally, ribosomal proteins themselves, when in
ribosome-free form, can regulate NF-κB signalling. The ribosomal protein L3 prevents the
degradation of IκB upon 5-fluorouracil treatment, thus repressing NF-κB activity [44,45], while
S3 promotes activity by interacting with NF-κB complexes in the nucleus [46]. Hence, there
are a number of signalling pathways by which stress-mediated nucleolar disruption could alter
NF-κB nuclear translocation and transcriptional activity.
Specific Nucleolar Disruption and Activation of the NF-κB Pathway
The first direct evidence that disruption of nucleolar homeostasis may activate NF-κB signalling
came from studies showing that depletion of the multifunctional nucleolar protein, nucleophosmin
(NPM, B23), induces degradation of IκB and nuclear translocation of RelA in colon cancer cells [47].
Depletion of the small nucleolar RNA host gene 15 (SNHG15) has also been shown to influence
NF-κB signalling in a renal cell carcinomamodel [48]. More recently, small interfering (si)RNA deple-
tion of the PolI complex components UBF, TIF-IA, or RPA194 (a component of PolI) was shown to
induce degradation of IκBα, S536 phosphorylation of RelA (a marker for activation), nuclear trans-
location of RelA, increased NF-κB transcriptional activity, and increased transcription of NF-κB tar-
get genes in multiple cell types [1]. Interestingly, this effect was not mimicked by actinomycin D,
CX5461, or BMH-21which block PolI transcription initiation (CX5461 and BMH-21) and elongation
(Actinomycin D) [49,50]. Hence, unlike p53 nucleolar stress response, the link between nucleolar
disruption and NF-κB activation is independent of rDNA transcription [21].
TIF-IA–NF-κB Nucleolar Stress Response
Recent studies, aimed at further exploration of nucleoli–NF-κB crosstalk, uncovered a novel pathway
by which nucleolar function is altered by stress and revealed this atypical nucleolar stress pathway
lies upstream of NF-κB signalling [1]. This new pathway is centred around the PIC component TIF-IA.
TIF-IA is themaster regulator of PolI-driven transcription [35,51]. Not only is it essential for anchor-
ing PolI to the rDNA promotor, it is also the component of the PIC that transduces environmental
signals to the PolI transcriptional machinery. Upon exposure of cells to exogenous stresses, TIF-
IA is targeted by a complex network of kinases and phosphatases including mammalian target of
rapamycin (mTOR), AMP-activated protein kinase (AMPK), extracellular signal-regulated kinase
(ERK), and protein phosphatase 2A (PP2A), which activate or inactivate the protein to fine-tune
the transcriptional output [51–54]. The consequences of TIF-IA inactivation are context4 Trends in Genetics, Month 2019, Vol. xx, No. xx
Trends in Geneticsdependent but in general, its loss leads to cell cycle arrest and apoptosis, confirming the impor-
tance of this protein as a critical regulator of cellular homeostasis [55–57].
Multiple stress stimuli of NF-kB, including aspirin, UV-C, and the second messenger ceramide,
not only alter the phosphorylation status of TIF-IA, but also induce degradation of the protein
[1]. This effect is not observed in response to TNFα or the DNA damaging agent camptothecin,
indicating specificity. The mechanism underlying stress-mediated TIF-IA degradation is complex
as it involves both proteasomal and lysosomal pathways. It is independent of MDM2, the E3 li-
gase reported to be responsible for basal TIF-IA turnover [58], suggesting it is distinct. Indeed,
stress-mediated TIF-IA degradation is dependent on dephosphorylation of TIF-IA at serine 44
(S44) and the PolI complex–associated factors UBF and p14ARF (Figure 2, Key Figure).
Cyclin-dependent kinase 4 (CDK4) is a key cell cycle protein that is inhibited in response to many
stress stimuli [59]. It is also known to phosphorylate UBF to regulate rDNA transcription [60]. It
was found that small-molecule inhibitors of CDK4 induce TIF-IA degradation by an identical
mechanism to that utilized by stress agents, that is, dependent on UBF, P14ARF, and dephos-
phorylation of TIF-IA at S44 [1]. Based on these data, it was concluded that stress-mediated
CDK4 inhibition lies upstream of TIF-IA degradation (Figure 2).
On exploration of the downstream consequences of TIF-IA degradation, it was noted that this
precedes degradation of IκBα and nuclear translocation of RelA/NF-κB, suggesting a potential
link. Indeed, blocking degradation of TIF-IA, using specific siRNAs and dominant negative UBF
and TIF-IA mutants, blocked the effects of specific stresses and CDK4 inhibitors on the NF-κB
pathway (Figure 2) [1]. These data revealed a novel TIF-IA–NF-κB nucleolar stress axis.
This novel nucleolar stress axis has now been observed in multiple mammalian cell types and in
human colorectal tumours treated ex vivo with the chemopreventive agent aspirin, suggesting
broad and in vivo relevance (see later) [1]. Although the signalling networks that link TIF-IA degra-
dation to NF-κB pathway activation are not yet clear, it has been proposed that release of NF-κB
regulatory proteins from the nucleolus to the nucleoplasm/cytoplasm upon TIF-IA degradation is
responsible. Further research in this area will help us fully understand how both nucleoli and NF-
κB regulate cellular homeostasis under normal and stress conditions.
TIF-IA, Nucleolar Enlargement, and Activation of the NF-κB Pathway
The nucleolus is a tripartite structure having three morphologically distinct subcompartments:
the fibrillar centre (FC), the dense fibrillar component (DFC), and the granular component (GC)
[14,61]. This structure is maintained by transcription of active rDNA and by liquid–liquid phase
separation of nucleolar components. It is highly dynamic and can dramatically change in size
and architecture depending on cellular environment [62,63]. Under conditions of stress, or if
rDNA transcription is inhibited, the FC and the DFC migrate to the periphery of the organelle
and form nucleolar caps in a process known as nucleolar segregation.
In general, nucleolar segregation is associated with a reduction in nucleolar size and
phosphorylation-mediated inactivation of TIF-IA has been implicated in this effect [51,54,56].
However, in contrast to phosphorylation-mediated inactivation, degradation of TIF-IA causes a
striking increase in nucleolar size, alongside inhibition of rDNA transcription and segregation of
nucleolar components (Figure 3) [1]. The mechanism underlying the connection between TIF-IA
loss and increased nucleolar size is currently unclear. However, an increase in nucleolar volume,
associated with altered rRNA transcription and nucleolar architecture, has also been observed in
response to the proteasome inhibitor MG132 [64] and the NEDD8 inhibitor MLN4924 [65]. TheseTrends in Genetics, Month 2019, Vol. xx, No. xx 5
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Figure 2. (1 and 2) When cells are exposed to specific stimuli, a cascade of events is triggered that leads to degradation o
TIF-IA in a manner dependent on inhibition of CDK4, recruitment of the nucleolar protein p14ARF, and the PolI complex
component UBF. This TIF-IA degradation has two consequences: (3a) a reduction in nucleolar number/increase in
nucleolar size and (3b) degradation of IκBα. IκBα degradation allows NF-κB to translocate to the nucleus and regulate
expression of target genes that control cellular processes such as apoptosis, proliferation, differentiation, and senescence
We speculate that disruption of the PolI complex causes specific NF-κB regulatory proteins (red spots) to translocate to
the cytoplasm to activate NF-kB signalling. These factors remain unknown. Abbreviations: ARF, p14ARF; CDK, cyclin-
dependent kinase; iκB, inhibitor of NF-κB; NF-κB, nuclear factor of κ-light-chain-enhancer of activated B cells; NSAID
nonsteroidal anti-inflammatory drug; UBF, upstream binding factor.
Trends in Genetics
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.
,data question the long-standing paradigm that nucleolar size is linked to the rate of rDNA tran-
scription. They also reveal a connection between TIF-IA, enlarged nucleoli, and activation of the
NF-κB pathway.
Nucleolar Size and NF-κB in Senescence and Ageing
One other scenario where enlargement of nucleoli is associated with activation of the NF-κB path-
way is in cellular senescence: a state of permanent cell cycle arrest that plays an important role in
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Figure 3. Nucleolar Sequestration of RelA Triggers a Nucleophosmin (NPM) Dependent, Nucleolar Apoptotic Pathway. (1) In diseased cells there is a
cytoplasmic, inducible pool of NF-κB and a nuclear pool that drives transcription of antiapoptotic, progrowth, and proinflammatory genes. (2) Exposure to specific
stress stimuli causes degradation of IκBα and nuclear translocation of NF-κB complexes. It also causes acetylation of COMMD, which is recruited by induced NF-κB
and facilitates ubiquitination of chromatin-bound RelA. (3) This ubiquitination causes nucleolar translocation of the protein and reduced NF-κB-driven transcription. The
nucleolar presence of RelA triggers cytoplasmic relocation of NPM. Here it binds BAX and transports BAX to the mitochondria to mediate apoptosis. Abbreviations:
iκB, inhibitor of NF-κB; NF-κB, nuclear factor of κ-light-chain-enhancer of activated B cells.
Trends in Geneticsdevelopment, tissue remodelling, cancer, and ageing [66]. A striking characteristic of senescence
is a large increase in nucleolar size and a reduction in nucleolar number [67]. Another striking
characteristic is increased NF-κB activity, which induces transcription of the inflammatory factors
that constitute the senescence-associated secretory phenotype (SASP) [68]. SASP is essential
for senescence as it reinforces cell cycle arrest, leads to paracrine senescence, and promotes se-
nescence surveillance [68]. Although SASP induction occurs in parallel with increased nucleolar
size and reduced number, it is currently unknown whether, in this context, nucleolar enlargement
and NF-κB pathway activation are linked. However, recent studies suggest that this may be a
possibility [67]. It has been shown that overexpression of TIF-IA in IMR90 primary human
fibroblasts not only caused an increase in nucleolar size, but also induced SASP factors in an
NF-κB-dependent manner. Nucleolar enlargement has recently been identified as a hallmark ofTrends in Genetics, Month 2019, Vol. xx, No. xx 7
Trends in Geneticsageing tissue [69,70], as is chronic activation of the NF-κB pathway [5]. It is now of considerable
interest to determine whether these events are linked in ageing and senescence and whether TIF-
IA plays a role in this process.
Nucleolar Sequestration of NF-κB Proteins Regulates Cell Growth and Death
Cellular stress causes not only a dynamic flux of regulatory proteins out of nucleoli, but also se-
questration of such proteins into the organelle [71–73]. This nucleolar sequestration has emerged
as an important mechanism for maintaining cellular homeostasis. It can regulate gene expression,
impact nuclear structure, modulate specific apoptotic pathways, and influence autophagy. It is
particularly prevalent under conditions of proteotoxic stress (e.g., proteasome inhibition) when
multiple proteins (e.g., p53, LC3II, sumoylated, and ubiquitinated proteins) translocate into the or-
ganelle and accumulate in structures termed nucleolar aggresomes or cavities [74–77].
Although themain switch in NF-κB activation is cytoplasmic release from IκB, once in the nucleus,
NF-κB proteins are modulated by a plethora of coactivators, repressors, and post-transcriptional
modifications [78]. These nuclear regulatory pathways are important because they determine the
genes that are activated or repressed by a specific signal and hence, the downstream conse-
quences on cell physiology. A growing body of evidence suggests that nucleolar sequestration
of NF-κB proteins is one such nuclear regulatory mechanism. For example, the anti-TNF therapy,
infliximab, induces ‘massive’ nucleolar localization of p50 in the hippocampus of rats with a
portacaval shunt [79]. This nucleolar localization is associated with a decrease in transcription
of NF-κB target genes and a reduction in neuroinflammation. p50 has also been shown to be se-
questered in nucleoli in a gastric cancer cell line [80]. Themost striking evidence that nucleolar se-
questration of NF-κB proteins regulates NF-κB activity comes from work on RelA. A large body of
evidence indicates RelA is sequestered in the nucleolus in response to stress. Furthermore, it has
been shown that once in nucleoli, RelA triggers a cascade of events that actively promotes
apoptosis.
Nucleolar Sequestration of RelA
When investigating nuclear regulation of NF-κB activity, it was noted that RelA is differentially
distributed within nuclei dependent on the stimulus [81]. In response to classic stimuli such as
TNF, the protein is distributed within the nucleoplasm, excluded from nucleoli (Figure 3). By con-
trast, it is localized to nucleoli in response to stress stimuli such as aspirin, UV-C radiation, and
serum starvation [81]. A nucleolar localization signal (NoLS) was identified at the N terminal of
RelA and, using a dominant negative mutant deleted for this motif, it was shown that nucleolar se-
questration of RelA is causally involved in repression of basal NF-κB-driven transcription and the
induction of apoptosis.
Since these original observations, nucleolar sequestration of RelA has been observed in a number of
other models. The nonsteroidal anti-inflammatory drugs sulindac, sulindac sulfone, and indomethacin
have been shown to induce nucleolar translocation of RelA in colon cancer cell lines [82]. This trans-
locationwas dependent on the NoLS andwas causally involved in the apoptotic effects of the agents.
Similar results have been shown for a small-molecule CDK4 inhibitor [59,83] and the proteasome in-
hibitors MG132 and lactacystin [84]. The antitumour agent 2-methoxyestradiol (a naturally occurring
derivative of estradiol) [85], the potent Trk inhibitor and antitumour agent K252a [86], and expression
of the homeobox transcription factor Hox-A5 [87] have also been shown to induce nucleolar translo-
cation of RelA associated with the induction of apoptosis.
It should be noted that most (although not all) of these studies have been carried out in colon can-
cer cell lines and others have failed to observe this phenomenon in other cell types exposed to8 Trends in Genetics, Month 2019, Vol. xx, No. xx
Trends in Geneticssimilar stresses. Hence, it is likely that nucleolar translocation of RelA is context dependent. Un-
derstanding the molecular signals that regulate the nuclear distribution of RelA would be highly
advantageous as it may allow the protein to be targeted to nucleoli in medical conditions driven
by hyperactivation of the NF-κB pathway (discussed later). These signals remain unclear. How-
ever, the multifunctional protein COMMD1 is emerging as an important determinant [84,88]. It
was shown that COMMD1 levels increase in response to specific stresses, that the protein facil-
itates the ubiquitination of RelA, and that RelA ubiquitination is essential for nucleolar translocation
of the protein [84]. It has subsequently been shown that TNF and the stress agent aspirin have
differential effects on the acetylation status of COMMD1, which could explain the differential dis-
tribution of RelA in response to these stimuli [88]. Interestingly, aspirin-mediated nucleoplasmic to
nucleolar translocation of RelA is blocked in the presence of the transcriptional inhibitor, Actino-
mycin D [81]. Since transcription of COMMD1 does not change in response to aspirin [88],
these data would suggest that additional factors may be involved.
RelA–Nucleophosmin Signalling
On exploring the mechanisms by which nucleolar RelA mediates apoptosis, a role for the multi-
functional phosphoprotein nucleophosmin (NPM, B23) was uncovered (Figure 3, Step 3). This
protein is predominantly nucleolar and plays a critical role in ribosome biogenesis [89]. However,
it can also be found in both the nucleoplasm and the cytoplasm and is known to regulate multiple
signalling networks [90]. In terms of NF-κB, NPM has been shown to act as a coactivator at spe-
cific genes sites and to be involved in activation of the NF-κB pathway in response to specific
stimuli [91–94].
It was originally presumed that nucleolar RelA causes apoptosis because the protein is seques-
tered away from promoters of antiapoptotic genes (Figure 3). However, using a nucleolar
targeting construct (RelA fused to the NoLS of the HIV-rev protein) it was shown that specifically
targeting RelA to this compartment induces apoptosis [95]. It is now known that once in the nu-
cleolus, RelA causes NPM to relocate to the cytoplasm, bind BAX, and then transport BAX to the
mitochondria to initiate apoptosis [95–98].
Therapeutic Relevance of Nucleoli–NF-κB Crosstalk: A Role in the Antitumour
Activity of Aspirin
Aberrant nucleolar activity is causally associated with progression of many common diseases
[4,99,100]. For example, hyperactivation induced by oncogenes and tumour suppressors contrib-
utes to cancer progression by allowing rapid protein synthesis and through dysregulation of nucle-
olar stress pathways [16,49]. Numerous studies implicate impairment of rDNA transcription in the
pathogenesis of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease while
structural changes to nucleoli are evident in ischemic heart disease [47,100,101]. Nucleolar size
and number also significantly correlate with longevity in a number of animal models [69,70]. Indeed,
it now appears that proper dynamic control of nucleolar activity is crucial for maintaining tissue ho-
meostasis and health. Similarly, aberrant NF-κB activity is a common event in cancer, neurodegen-
erative disorders, and ageing and contributes to the aetiology of these conditions by activating
progrowth/antiapoptotic genes, promoting a chronic inflammatory state and inducing senescence
[2,5,102,103]. Further investigations into the links between nucleoli and NF-κB may allow the de-
velopment of therapeutics that target both pathways simultaneously. One agent that has already
been shown to act through nucleolar–NF-κB crosstalk is aspirin.
Overwhelming evidence indicates that aspirin and related agents have considerable antitumour
activity and the potential to prevent colorectal and other cancers [104,105]. Epidemiological
and experimental evidence also suggests that aspirin use prevents against neurodegenerativeTrends in Genetics, Month 2019, Vol. xx, No. xx 9
Trends in Geneticsdisorders such as Alzheimer’s disease [106]. However, aspirin cannot be recommended for pre-
vention purposes due to its side effect profile.
In experiments aimed at understanding the mechanism of action of aspirin against colorectal can-
cer, it was found that the agent causes degradation of TIF-IA and inhibition of rDNA transcription
[1]. Furthermore, it was shown that this degradation is causally linked to stimulation of the NF-κB
pathway and consequently, sequestration of RelA to nucleoli, repression of NF-κB activity, and
apoptosis (Figure 4) [81,95,107].
A link between TIF-IA degradation and NF-κB signalling was observed in multiple colon cancer
cells lines, in cell lines derived from human premalignant intestinal lesions, and in four of seven
human tumours treated ex vivo with low doses of the agent, suggesting pharmacological rele-
vance [1]. These data reveal a novel and exciting mechanism of action of aspirin that warrants fur-
ther investigation not only in cancer models, but also in models of other diseases associated with
dysregulation of NF-κB and nucleolar pathways.
In addition to aspirin, a small-molecule CDK4 inhibitor has been shown to induce degradation
of TIF-IA, which is causally linked to stimulation of the NF-κB pathway and the induction of
apoptosis (Figure 2) [1,83]. These data reveal another class of agents that simultaneously
inhibit rDNA transcription and NF-κB activity. Responses to aspirin are generally restricted to
colon cancer cells [108]. By contrast, CDK4 inhibition caused TIF-IA-dependent NF-κB
pathway stimulation in multiple cell types, suggesting crosstalk between these pathways can
be broadly targeted [1].Trends in Genetics
Figure 4. Nucleoli–NF-κB Crosstalk in Aspirin Response. High levels of PolI- and NF-κB-driven transcription drive colon cancer progression. Exposure to the
antitumour agent aspirin causes TIF-IA degradation, which inhibits rDNA transcription and stimulates cytoplasmic to nuclear translocation of RelA. This induced NF-κB
recruits factors to chromatin-bound NF-κB which target RelA to the nucleolus. Nucleolar sequestration of RelA causes apoptosis of diseased cells by switching off NF-
κB activity and triggering relocation of nucleophosmin (NPM) from nucleoli. Abbreviations: CDK, cyclin-dependent kinase; iκB, inhibitor of NF-κB; NF-κB, nuclear factor
of κ-light-chain-enhancer of activated B cells; PolI, RNA polymerase I; UBF, upstream binding factor.
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Outstanding Questions
What are the signalling networks that
link degradation of TIF-IA to increased
nucleolar size and activation of the
NF-κB pathway? Is NF-κB pathway
activation a consequence of changes
in nucleolar number/structure? What
are the biological contexts in which
this signalling network is relevant?
Does it play a role in ageing and senes-
cence? Understanding the molecular
links between PolI complex disruption
and NF-κB pathway activation could
open exciting new opportunities to in-
tervene therapeutically in pathologies
associated with dysfunction of both
nucleoli and NF-κB.
How is NF-κB modulated by acety-
lated COMMD1 to allow nucleolar
translocation? What are the carriers
Trends in GeneticsConcluding Remarks and Future Directions
In the past two decades, the nucleolus has emerged as a multifunctional organelle, regulating
processes that go well beyond its traditional role in ribosome biogenesis. One of its more recently
identified functions is as a central coordinator of stress response. Although it remains unclear how
the organelle choreographs specific cellular outcomes following exposure to specific stresses,
there is an intriguing and growing body of evidence to suggest that links between nucleoli and
the NF-κB pathway play a key role. However, this field is still in its infancy. Evidence for a link
between TIF-IA, nucleolar size, and NF-κB pathway activation is compelling, but further research
is essential to understand the molecular signals that drive the relationship, the cellular contexts in
which it is evident, and whether it plays a role in senescence and ageing. Similarly, it is important
to understand the pathways responsible for nucleolar sequestration of NF-kB and other
proteins so that these can be exploited for therapeutic purpose. Given the number of common
ageing disorders associated with dysfunction of both nucleoli and NF-κB, we speculate that
crosstalk between these pathways is a contributing factor. In the future, it will be fascinating
to molecularly deconstruct the nucleolar–NF-κB signalling network to understand exactly
how this network is regulated in normal cells, and whether dysfunction contributes to disease
(see Outstanding Questions).Acknowledgements
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